Long Nursing Shifts Linked to Job Dissatisfaction, Burnout

This article originally appeared here.
Share this content:
Long Nursing Shifts Linked to Job Dissatisfaction, Burnout
Long Nursing Shifts Linked to Job Dissatisfaction, Burnout

FRIDAY, Sept. 11, 2015 (HealthDay News) -- For nurses, shifts that last 12 hours or more are associated with a 40 percent higher level of job discontentment and a 31 percent higher risk of planning to quit when compared with shifts that are eight hours or less, according to a report published online Sept. 10 in BMJ Open.

Researchers surveyed 31,627 registered nurses from 488 hospitals in 12 European countries. The average age of the nurses was 38, and most were women. Half of the study participants worked eight-hour or shorter shifts. Nearly one-third of the nurses worked shifts lasting eight to 10 hours. Four percent worked up to 12 hours, and 14 percent worked 12 to 13 hours at a time. Only 1 percent of those polled worked shifts that lasted more than 13 hours.

The researchers found that about 25 percent of the nurses said they weren't satisfied with their job. A similar percentage was also not happy with the flexibility of their work schedule. One-third of the nurses surveyed said they planned to leave their job. Working overtime was linked to poor outcomes in all aspects of job satisfaction -- regardless of how many extra hours they worked.

"Current literature tends to report that 12-hour shifts represent a way to retain nurses in hospital clinical practice because it is believed to be the preferred shift length and that nurses are more satisfied with their jobs: our results suggest the opposite," study author Chiara Dall'Ora, from the University of Southampton in the United Kingdom, and colleagues write. "Therefore, our findings pose substantial questions for managers, most notably because job satisfaction is a consistent and robust predictor of remaining in a job."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths